SAA receives no government funding and relies on the generous donations from individuals to create and maintain the programs and services aimed at improving the futures of the 3.2 million Americans affected by spondyloarthritis.
Two recent studies have come out pointing to the same conclusion: The…
Biologic medications, including TNF inhibitors (TNFi) and interleukin-17…
An interview with Steve Lee, DO, FACR, rheumatologist and member of SAA’s Medical and Scientific Advisory Board. We’re…
An interview with rheumatologist, researcher, AS patient, and long-time member of SAA’s Medical and Scientific Advisory Board, Muhammad…
A flare can be defined as the acute worsening of symptoms. Flares are generally thought to be due to increased activity of the underlying disease…
We sat down with Dr. John Reveille to discuss the HLA-B27, ethnicity, and other factors that may affect…
How many people in the U.S. have spondyloarthritis? One might think this…
Dr. Mechiel Korte has extensive expertise as an esteemed researcher dedicated to…
Findings and Recommendations In September of this year the American College of Rheumatology released the first ever recommendations for physicians in the US for the…
Input your search keywords and press Enter.
